Gr. Sigurdardottir et al., Cardiovascular effects of domperidone in patients with Parkinson's diseasetreated with apomorphine, ACT NEUR SC, 104(2), 2001, pp. 92-96
Objectives - The cardiovascular effects of the peripheral dopamine D2-recep
tor antagonist domperidone were studied in patients with idiopathic Parkins
on's disease treated with continuous subcutaneous infusion of apomorphine.
Material and methods - Blood pressure and heart rate of 10 patients were mo
nitored for 24 h before and after treatment with domperidone using. an auto
matic device for blood pressure recording. Results - Blood pressure and hea
rt rate increased significantly during 24 h of domperidone treatment. When
day and night values were analysed separately, a significant difference of
blood pressure between the groups was found only during the day whereas hea
rt rate was significantly increased during both day and night. Domperidone
shifted blood pressure and heart rate upwards without affecting the rop of
blood pressure in the erect position. Conclusion - Domperidone increases bl
ood pressure and heart rate without inducing nocturnal hypertension in apom
orphine treated patients with idiopathic Parkinson's disease. Increased hea
rt rate by domperidone is a new finding but the clinical significance is un
clear and requires further investigation.